| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3462202
[patent_doc_number] => 05468753
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-11-21
[patent_title] => 'Use of a 1-(2-naphthylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridi ne for the manufacture of a medicament for the treatment of cerebral and neuronal diseases'
[patent_app_type] => 1
[patent_app_number] => 8/142069
[patent_app_country] => US
[patent_app_date] => 1993-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3879
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/468/05468753.pdf
[firstpage_image] =>[orig_patent_app_number] => 142069
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/142069 | Use of a 1-(2-naphthylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridi ne for the manufacture of a medicament for the treatment of cerebral and neuronal diseases | Oct 19, 1993 | Issued |
Array
(
[id] => 3624102
[patent_doc_number] => 05602166
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-11
[patent_title] => 'Cytokine inhibitors'
[patent_app_type] => 1
[patent_app_number] => 8/138178
[patent_app_country] => US
[patent_app_date] => 1993-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3006
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/602/05602166.pdf
[firstpage_image] =>[orig_patent_app_number] => 138178
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/138178 | Cytokine inhibitors | Oct 14, 1993 | Issued |
Array
(
[id] => 3441981
[patent_doc_number] => 05397570
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-03-14
[patent_title] => 'Antibiotics AB-023 and process for preparing them'
[patent_app_type] => 1
[patent_app_number] => 8/136754
[patent_app_country] => US
[patent_app_date] => 1993-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 5980
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/397/05397570.pdf
[firstpage_image] =>[orig_patent_app_number] => 136754
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/136754 | Antibiotics AB-023 and process for preparing them | Oct 14, 1993 | Issued |
| 08/137397 | METHOD OF CONTROLLING TUMOR GROWTH RATE | Oct 13, 1993 | Abandoned |
| 08/135862 | ANTIBIOTIC GE 2270 FACTORS A1, A2, A3 & H | Oct 12, 1993 | Abandoned |
| 08/129103 | ANTIMALARIAL SYNERGISTIC COMBINATIONS CONTRAINING BENFLUMETOL | Sep 29, 1993 | Abandoned |
| 08/129526 | RAPAMYCIN FORMULATION FOR IV INJECTION | Sep 29, 1993 | Abandoned |
| 08/128843 | METHOD FOR THE TREATMENT OF NEOPLASTIC DISEASE UTILIZING TAXOL AND TIAZOFURIN | Sep 28, 1993 | Abandoned |
Array
(
[id] => 3564811
[patent_doc_number] => 05484612
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-01-16
[patent_title] => 'Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin'
[patent_app_type] => 1
[patent_app_number] => 8/125609
[patent_app_country] => US
[patent_app_date] => 1993-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 12380
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/484/05484612.pdf
[firstpage_image] =>[orig_patent_app_number] => 125609
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/125609 | Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin | Sep 21, 1993 | Issued |
Array
(
[id] => 3477336
[patent_doc_number] => 05432187
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-07-11
[patent_title] => 'Benzimidazole anthelmintic in the treatment of microsporidial infections'
[patent_app_type] => 1
[patent_app_number] => 8/117160
[patent_app_country] => US
[patent_app_date] => 1993-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 608
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/432/05432187.pdf
[firstpage_image] =>[orig_patent_app_number] => 117160
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/117160 | Benzimidazole anthelmintic in the treatment of microsporidial infections | Sep 14, 1993 | Issued |
| 08/122022 | REGULATING RETROVIRAL REPLICATION, INFECTION, AND PATHOGENESIS | Sep 13, 1993 | Abandoned |
Array
(
[id] => 3517796
[patent_doc_number] => 05486535
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-01-23
[patent_title] => 'Method for treating toxoplasmosis'
[patent_app_type] => 1
[patent_app_number] => 8/117414
[patent_app_country] => US
[patent_app_date] => 1993-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8055
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/486/05486535.pdf
[firstpage_image] =>[orig_patent_app_number] => 117414
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/117414 | Method for treating toxoplasmosis | Sep 6, 1993 | Issued |
Array
(
[id] => 3687252
[patent_doc_number] => 05663196
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-02
[patent_title] => 'Methods for treating neoplastic disorders'
[patent_app_type] => 1
[patent_app_number] => 8/116689
[patent_app_country] => US
[patent_app_date] => 1993-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 14
[patent_no_of_words] => 12877
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 248
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/663/05663196.pdf
[firstpage_image] =>[orig_patent_app_number] => 116689
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/116689 | Methods for treating neoplastic disorders | Sep 2, 1993 | Issued |
Array
(
[id] => 3443118
[patent_doc_number] => 05466700
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-11-14
[patent_title] => 'Anesthetic use of N-phenyl-N-(4-piperidinyl)amides'
[patent_app_type] => 1
[patent_app_number] => 8/114032
[patent_app_country] => US
[patent_app_date] => 1993-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6382
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/466/05466700.pdf
[firstpage_image] =>[orig_patent_app_number] => 114032
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/114032 | Anesthetic use of N-phenyl-N-(4-piperidinyl)amides | Aug 29, 1993 | Issued |
| 08/112849 | IMMUNOPOTENTIATORY AGENT AND PHYSIOLOGICALLY ACCEPTABLE SALTS THEREOF | Aug 25, 1993 | Abandoned |
Array
(
[id] => 3666361
[patent_doc_number] => 05599789
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-04
[patent_title] => 'Method for the treatment of tumours and sarcomas'
[patent_app_type] => 1
[patent_app_number] => 8/107767
[patent_app_country] => US
[patent_app_date] => 1993-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6253
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/599/05599789.pdf
[firstpage_image] =>[orig_patent_app_number] => 107767
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/107767 | Method for the treatment of tumours and sarcomas | Aug 23, 1993 | Issued |
Array
(
[id] => 3896357
[patent_doc_number] => 05750557
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-12
[patent_title] => 'Method and pharmaceutical formulation for treating benign prostatic hyperplasia'
[patent_app_type] => 1
[patent_app_number] => 8/111014
[patent_app_country] => US
[patent_app_date] => 1993-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6008
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/750/05750557.pdf
[firstpage_image] =>[orig_patent_app_number] => 111014
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/111014 | Method and pharmaceutical formulation for treating benign prostatic hyperplasia | Aug 23, 1993 | Issued |
| 08/111045 | ANTIBIOTIC STALOBACINS | Aug 23, 1993 | Abandoned |
| 08/107723 | TREATMENT OF ESOPHAGEAL CANCER | Aug 19, 1993 | Abandoned |
| 08/107743 | TREATMENT OF OVARIAN CANCER | Aug 19, 1993 | Abandoned |